Shares of Walgreen Boots Alliance and Rite Aid are trading lower after the merger of the two drugstore companies is facing US antitrust concerns. » Read More
By: Rachel Cao
The Apple chip provider reported first quarter earnings of $1.61 per share on revenues of $914 million. » Read More
By: Bob Pisani
Trump offered precious little about the issues that would matter most to earnings: tax cuts and infrastructure spending. » Read More
Shares of Cirrus Logic spiked Thursday, following the company's release of quarterly earnings and a strong outlook.
We're at the halfway mark for earnings, with more than half of the S&P 500 reporting as of this morning. Bob Pisani brings you the good news, so far.
CEO Tom Fallon said that "demand is softening in certain areas of our business and we face a difficult near-term revenue outlook."
MKM just lowered its rating on Activision Blizzard to neutral from buy.
GoPro's stock spiked nearly 9 percent Thursday after the company posted its quarterly results.
The last of the FANG stocks are set to report earnings Thursday and traders are expecting some big moves from the mega-cap names.
Groupon CEO Rich Williams tells CNBC the daily deals company is fighting for customers but not for its very survival.
Jim Cramer said Facebook's Mark Zuckerberg is a "big thinker," citing his push for live video, virtual reality and messenger chatbots.
Monness Crespi Hardt just lowered its rating on Facebook to neutral from buy.
"The belief generally on the Street, 'As goes oil prices, so goes stock prices,' that's nonsense," Dennis Gartman tells CNBC.
Whole Foods Market shares fell more than 8 percent, as investors worried about the tough competition it faces.
Garmin shares soared Wednesday after the company reported second-quarter earnings that blew estimates out of the water.
Some of the names on the move ahead of the open.
Jim Cramer highlighted one sector as a major area of weakness in the market.
Jim Cramer outlined the short-seller double cross that hit the market and trapped the bears on various stocks on Wednesday.
Alere is still is trying to close its multibillion-dollar purchase by Abbott Labs.
Get the best of CNBC in your inbox